concanavalin A
METHODS: Basal, concanavalin A (Con A)-, and       phorbol-12-myristate-13-acetate (PMA)-stimulated lymphocyte PC-1, aminopeptidase        N (APN), and dipeptidylpeptidase IV (DPP IV) activities were determined in 16       patients with Type 2 diabetes before and after 3 months of metformin treatment.
METHODS: Basal,  @SUBJECT$  (Con A)-, and       phorbol-12-myristate-13-acetate (PMA)- @PREDICAT$  lymphocyte PC-1,  @OBJECT$  (APN), and dipeptidylpeptidase IV (DPP IV) activities were determined in 16       patients with Type 2 diabetes before and after 3 months of metformin treatment.